Fabienne Le Gac

发表

Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer.

E. Winer, G. Hortobagyi, F. André, 2022, The New England journal of medicine.

Impact of ribociclib (RIB) dose modifications (mod) on overall survival (OS) in patients (pts) with HR+/HER2- advanced breast cancer (ABC) in MONALEESA(ML)-2.

P. Neven, A. Bardia, L. Hart, 2022, Journal of Clinical Oncology.